Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catharine M L West

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|February 10, 2022
Hypoxia does not predict lack of benefit from adjuvant radiotherapy for patients with early stage breast cancerCatharine M L West
Journal of the National Cancer Institute|July 30, 2020
Identifying the Radioresponsive Genome for Genomics-Guided RadiotherapyCatharine M L West
Anti-Cancer Drugs|March 12, 2004
Combretastatin A4 phosphateCatharine M L West, Pat Price
Current Opinion in Supportive and Palliative Care|March 6, 2009
Measurement tools for gastrointestinal symptoms in radiation oncologyCatharine M L West, Susan E Davidson
Nature Reviews. Cancer|June 2, 2004
The potential of positron-emission tomography to study anticancer-drug resistanceCatharine M L West, Terry Jones, Pat Price
Discovery Medicine|August 14, 2010
Positron emission tomography (PET) and anticancer drug developmentCatharine M L West, Terry Jones, Pat Price
Nature Reviews. Clinical Oncology|December 8, 2022
Predicting tumour radiosensitivity to deliver precision radiotherapyJames M Price, Asmithaa Prabhakaran, Catharine M L West
Seminars in Radiation Oncology|March 6, 2012
Genome-wide association studies and prediction of normal tissue toxicityCatharine M L West, Alison M Dunning, Barry S Rosenstein
International Journal of Radiation Oncology, Biology, Physics|June 26, 2025
In Reply to Bassi and HarrisCatharine M L West, James M Price, David J Thomson
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2002
Relationship between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiation reactions: a comparison of training and validation cohorts of breast cancer patientsJeanette Dickson, Brian Magee, Alan Stewart, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|February 10, 2022
Hypoxia does not predict lack of benefit from adjuvant radiotherapy for patients with early stage breast cancerCatharine M L West
Journal of the National Cancer Institute|July 30, 2020
Identifying the Radioresponsive Genome for Genomics-Guided RadiotherapyCatharine M L West
Anti-Cancer Drugs|March 12, 2004
Combretastatin A4 phosphateCatharine M L West, Pat Price
Current Opinion in Supportive and Palliative Care|March 6, 2009
Measurement tools for gastrointestinal symptoms in radiation oncologyCatharine M L West, Susan E Davidson
Nature Reviews. Cancer|June 2, 2004
The potential of positron-emission tomography to study anticancer-drug resistanceCatharine M L West, Terry Jones, Pat Price
Discovery Medicine|August 14, 2010
Positron emission tomography (PET) and anticancer drug developmentCatharine M L West, Terry Jones, Pat Price
Nature Reviews. Clinical Oncology|December 8, 2022
Predicting tumour radiosensitivity to deliver precision radiotherapyJames M Price, Asmithaa Prabhakaran, Catharine M L West
Seminars in Radiation Oncology|March 6, 2012
Genome-wide association studies and prediction of normal tissue toxicityCatharine M L West, Alison M Dunning, Barry S Rosenstein
International Journal of Radiation Oncology, Biology, Physics|June 26, 2025
In Reply to Bassi and HarrisCatharine M L West, James M Price, David J Thomson
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2002
Relationship between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiation reactions: a comparison of training and validation cohorts of breast cancer patientsJeanette Dickson, Brian Magee, Alan Stewart, et al.
Pageof 12